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The rapid emergence of extended-spectrum beta-lactamase (ESBL)-producing *Escherichia coli* in the community has prompted search for sources in the animal population. Food animals are a well-studied animal reservoir, but companion animals, in particular dogs, may also be colonised or infected with these cephalosporin-resistant *E. coli* \[[@CR1]\]. The prevalence of ESBL carriage in dogs varies considerably between countries with the highest frequency (55 %) being reported in diarrheic dogs in The Netherlands \[[@CR2]\]. Faecal shedding of ESBL-producing *E. coli* by dogs was recently shown to be highly dynamic with the majority of dogs being intermittent shedders and positive for different ESBL genes over time \[[@CR3]\]. The most common ESBL type found in canine *E. coli* is CTX-M, which also predominates in humans and other animals including livestock and wild animals \[[@CR1], [@CR4], [@CR5]\].

The close contact between dogs and humans implies risks of zoonotic transmission for a variety of pathogens, especially by the faecal-oral route \[[@CR6]\]. Dog faeces are a recognized source of zoonotic agents, including clinically relevant resistant bacteria that can be transmitted to humans through direct exposure or via contamination of domestic and public environments. The objective of this study was to provide data on the prevalence and types of ESBL-producing *E. coli* in dog faecal deposits in public gardens.

In April and May 2013, 209 faecal samples were collected from trashcans in nine public gardens (5--40 samples per park) in the Greater Copenhagen area, Denmark. All samples were contained in plastic bags and supposedly less than 2 days old, since trashcans in these gardens are emptied at least every other day by the municipality. Each garden was visited only once to limit the risk of getting more than one sample per dog.

Samples were processed in the laboratory on the day of collection. One gram of each sample was suspended 1:10 in MacConkey broth (Oxoid, Basingstoke, UK) supplemented with 1 mg/l cefotaxime. Following overnight incubation with shaking at 37 °C, 10 µl of the enrichment culture was plated onto MacConkey agar (Oxoid) containing 1 mg/l cefotaxime. After incubation (24 h, 37 °C), one presumptive *E. coli* was sub-cultured from samples displaying growth and stored at −80 °C prior to further analyses. Multiple colonies were stored if more than one colony morphology was visible on the same plate.

Presumptive *E. coli* isolates were confirmed by matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) mass spectrometry (Vitek MS RUO; bioMérieux, France) using *E. coli* ATCC 8739 as reference strain and Saramis™ 3.5 (bioMérieux) for spectra interpretation. Antibiotic susceptibility was tested by broth microdilution using Sensititre COMPAN1F plates (Thermo Fisher Scientific, Hvidovre, Denmark). Susceptibility to amoxicillin clavulanate, cefoxitin, cefpodoxime, imipenem, and the non-beta-lactams amikacin, chloramphenicol, doxycycline, enrofloxacin, gentamicin, marbofloxacin, and sulfamethoxazole/trimethoprim was interpreted according to the Clinical and Laboratory Standards Institute guidelines \[[@CR7]\].

Genes encoding the most common ESBL types (*bla*~CTX-M~, *bla*~TEM~ and *bla*~SHV~) and plasmid-encoded AmpC beta-lactamase (*bla*~CMY-2~) were detected by polymerase chain reaction (PCR) and sequenced \[[@CR8], [@CR9]\]. Positive isolates were characterized by multilocus sequence typing (MLST) and assigned to sequence types (STs) using the *E. coli* MLST database (<http://mlst-warwick.ac.uk>[)]{.ul}.

Plasmid DNA purified by alkaline lysis was transformed into electrocompetent Genehog *E. coli* (Invitrogen, Carlsbad, USA) followed by selection of transformants on Müller Hinton agar (Oxoid, Basingstoke, UK) supplemented with 1 mg/l cefotaxime. Transformants verified by colony PCR were subjected to S1 nuclease pulsed field gel electrophoresis (PFGE) \[[@CR10]\], PCR-based replicon typing (PBRT) (Diatheva, Fano, Italy), and antimicrobial susceptibility testing (as described above). IncI1 plasmids were subtyped by plasmid MLST (pMLST) \[[@CR11]\].

Four faecal deposits (1.9 %) collected in two gardens displayed growth of lactose-positive colonies, and additional growth of lactose-negative colonies was detected in one of these samples. All colonies were identified as *E. coli* and harboured one or more genes encoding β-lactamase, namely *bla*~CTX-M-1~ (n = 3), *bla*~CTX-M-15~ (n = 2) and *bla*~TEM-1~ (n = 2) (Table [1](#Tab1){ref-type="table"}). Each isolate belonged to a distinct genotype (ST59, ST609, ST4304, ST4305 or ST4340). The five strains were resistant to cefpodoxime and susceptible to amoxicillin clavulanate, cefoxitin, aminoglycosides and chloramphenicol. Susceptibility to fluoroquinolones, sulfamethoxazole/trimethoprim and doxycycline varied depending on the strain (Table [1](#Tab1){ref-type="table"}).Table 1Genotypic and phenotypic features of cefotaxime-resistant *Escherichia coli* isolated from dog faecal depositsStrain IDPublic gardenFaecal depositCefotaxime-resistant *E. coli*CTX-M-encoding plasmid*bla* gene(s)Resistance to non-beta-lactamsMLST typeReplicon(s)pMLST typeSize (kb)Co-transferred resistance147A1*bla* ~CTX-M-1~NoneST59I1ST5878None115B2*bla* ~CTX-M-1~SXTST4340I1ST5878None122B3*bla* ~CTX-M-1~ *bla* ~TEM-1~DOX, SXTST4304I1ST3104SXT104g^a^B4*bla* ~CTX-M-15~ENR, MARST4305Non-typeableNA104None104r^b^B4*bla* ~CTX-M-15~ *bla* ~TEM-1~DOX, SXTST609FIB, YNA95SXT*ENR* enrofloxacin, *DOX* doxycycline, *MAR* marbofloxacin, *SXT* sulfamethoxazole/trimethoprim, *NA* not applicable^a^Lactose-negative strain^b^Lactose-positive strain

Plasmids carrying ESBL genes varied from approximately 78 to 104 Kb. *bla*~CTX-M-1~ was found in three strains on IncI1 plasmids assigned to ST58 (n = 2) or ST3 (n = 1) by pMLST. *bla*~CTX-M-15~ was detected in the lactose-positive and the lactose-negative isolates from the same sample on distinct plasmids, one positive for both the FIB and the Y replicon types, and the other one non-typeable by PBRT. Resistance to sulfamethoxazole and trimethoprim was co-transferred by the two plasmids IncI1 ST3 and FIB/Y (Table [1](#Tab1){ref-type="table"}).

The observed prevalence of 1.9 % ESBL-producing *E. coli* in dog faecal deposits is generally lower than reported in healthy dogs in other European studies \[[@CR2], [@CR12], [@CR13]\]. This difference may indicate a low prevalence of ESBL-producing *E. coli* in the Danish dog population but could also be due to differences in study population, sample collection or processing. In fact, most other studies reported on fresh samples obtained directly from dogs. The high local variation with most ESBL-positive samples deriving from public garden B (Table [1](#Tab1){ref-type="table"}) may reflect the relatively high number of samples (n = 40) collected in this garden, but otherwise is difficult to explain given the close proximity of the gardens (within a 7 km diameter zone) and the common municipal practice for emptying of waste bins. One recent study detected ESBL or AmpC-producing *E. coli* in 14 % of faecal deposits collected near a small animal hospital in Germany \[[@CR14]\]. This high prevalence was likely influenced by the study location and associated antimicrobial selective pressure, since some clones were also detected in hospitalized dogs. Both that and the present study found a clear predominance of *bla*~CTX-M-1~ and *bla*~CTX-M-15~ among isolates, thus confirming previous evidence that these ESBL-types are the most frequent in dogs in Europe \[[@CR1], [@CR3], [@CR15]\]. The ESBLs were found in different *E. coli* genetic backgrounds, including three newly described STs (ST4304, ST4305 and ST4340) and one genotype (ST59) that has previously been associated to a human-specific pathotype \[[@CR16]\]. Our failure to detect CMY-2 was however unexpected, as this plasmid-mediated AmpC β-lactamase is frequent among cephalosporin-resistant *E. coli* isolated from dogs in Denmark \[[@CR17]\] as well as in other EU countries \[[@CR18]\] and continents \[[@CR19]--[@CR21]\].

The association of *bla*~CTX-M-1~ with IncI1 plasmids is well known in *E. coli* from humans and several animal species across Europe. Within this incompatibility group, ST3 plasmids harbouring *bla*~CTX-M-1~ have been reported in different animal species in Denmark, France, Switzerland and Tunisia \[[@CR13], [@CR22]--[@CR25]\], suggesting that this specific IncI1 plasmid lineage has no geographic or host barriers. The other IncI1 plasmid detected in association with *bla*~CTX-M-1~ (ST58) plasmids is less frequently reported but was recently described in human CTX-M-1-producing *E. coli* isolates from Danish patients \[[@CR24]\].

CTX-M-15 is the most frequent ESBL type in human clinical *E. coli* isolates in most EU countries, often in association with IncF plasmids \[[@CR4]\]. We found *bla*~CTX-M-15~ on IncFIB/IncY and non-typeable plasmids in two genetically distinct *E. coli* strains originating from the same sample (Table [1](#Tab1){ref-type="table"}). Multireplicon plasmid IncFIB/IncY have not been reported previously, although another hybrid replicon (IncY/IncA/C) was described in association with *bla*~CTX-M-15~ in *Salmonella* Concord isolated from humans in France \[[@CR26]\]. Our results suggest that the dog from which the sample derived had been exposed to CTX-M-15-producing *E. coli* on at least two occasions or that recombination took place between different plasmids and strains. This second hypothesis is supported by the fact that the IncY replicon is also found on phages, and several plasmids non-typeable by PBRT in *E. coli* are indeed phages \[[@CR27]\].

A limitation of the study is that samples were inside plastic bags upon collection and therefore not fully representing the faecal deposits that people may encounter on the ground. However, we deliberately chose this sampling strategy to minimize the risk of collecting samples from the same dog more than once.

The study shows that dog faeces are a vector for dissemination of CTX-M-producing *E. coli* within urban areas. The risk derived from human exposure to dog faeces in public gardens is highlighted by the isolation of *E. coli* and plasmid lineages previously detected in human infections. This risk appears to be low in Copenhagen but could be significantly higher in other geographical areas where these bacteria are prevalent in the dog population and the practice of removing and disposing dog faeces is not well established among dog owners. In view of this and the potential for other zoonotic pathogens in dog faeces \[[@CR6]\], owners should be encouraged to dispose dog faecal deposits and to practice hand hygienic procedures afterwards, for example by using a hand rub disinfectant.
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